Centiva Capital’s Veracyte VCYT Stock Holding History

Centiva Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,256	Closed	-$450K	–	1624
2021 Q2	$450K	Buy	+11,256	New	+$481K	0.01%	873

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Centiva Capital's VCYT Position: Q3 2021 in Review

Centiva Capital sold out of Veracyte (VCYT) in Q3 2021, closing a stake of 11,256 shares — an estimated $450K sold.

Centiva Capital first reported a position in VCYT in Q2 2021 and held it in 1 quarter. The position peaked at $450K in Q2 2021. 214 funds tracked by Wall St. Rank hold VCYT as of Q3 2021.

Centiva Capital reported no remaining Veracyte position as of Q3 2021 after selling out during the quarter.
Centiva Capital sold 11,256 Veracyte shares in Q3 2021, an estimated $450K.
Centiva Capital first reported a position in Veracyte in Q2 2021 and held it in 1 quarter.
Centiva Capital's Veracyte position peaked at $450K in Q2 2021.
214 funds tracked by Wall St. Rank held Veracyte as of Q3 2021.

Based on Centiva Capital's 13F filing for Q3 2021, filed 15 Nov 2021.